Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The receptor tyrosine kinase EphA2 is found to be an important determinant of EBV entry and fusion in epithelial cells. EphA2 depletion or absence, or the use of anti-EphA2 antibodies, inhibits oropharyngeal epithelial cell infection.
The receptor tyrosine kinase EphA2 is identified as an EBV entry and fusion receptor in epithelial cells. EphA2 depletion or absence, or the use of anti-EphA2 antibodies, precludes infection of epithelial cell lines and oropharyngeal carcinoma cells.